2020
DOI: 10.1038/s41392-020-00342-0
|View full text |Cite
|
Sign up to set email alerts
|

Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting

Abstract: Therapeutic efficacy against cancer relies heavily on the ability of the therapeutic agents to reach their final targets. The optimal targets of most cancer therapeutic agents are usually biological macromolecules at the subcellular level, which play a key role in carcinogenesis. Therefore, to improve the therapeutic efficiency of drugs, researchers need to focus on delivering not only the therapeutic agents to the target tissues and cells but also the drugs to the relevant subcellular structures. In this revi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
64
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 91 publications
(65 citation statements)
references
References 153 publications
(122 reference statements)
0
64
0
1
Order By: Relevance
“…9,37 Apart from the present well-known anti-cancer drugs, there's a need to develop more effective nano-formulations for safer and more efficacious therapy. 32,33,38,39 With this perspective, we designed our novel study based on microbial transglutaminase nanoowers, which to the best of our knowledge, is a new and state-of-art approach. For anti-cancer therapy, this will be the rst anticipated novel enzymatic transglutaminase nanoowers coming into action as a nano-drug.…”
Section: Introductionmentioning
confidence: 99%
“…9,37 Apart from the present well-known anti-cancer drugs, there's a need to develop more effective nano-formulations for safer and more efficacious therapy. 32,33,38,39 With this perspective, we designed our novel study based on microbial transglutaminase nanoowers, which to the best of our knowledge, is a new and state-of-art approach. For anti-cancer therapy, this will be the rst anticipated novel enzymatic transglutaminase nanoowers coming into action as a nano-drug.…”
Section: Introductionmentioning
confidence: 99%
“…The nonfixation approach might confirm the feasibility of the endocytosis procedure in living cells instead of creating artificial porousness on the cell membrane by fixative reagents. Innumerable studies have experimented with various strategies for targeting subcellular organelles with macromolecules and nanoparticles [46,47]. Among these approaches, confocal imaging has been heavily utilized for cellular imaging, but due to restrictions with light imaging, the resolution cannot be sufficient for visualizing the details of organelles in cells; therefore, we employed cryo-EM to elevate the resolution of microscopy from the deliberated mitochondria targeted by UCNPs.…”
Section: Resultsmentioning
confidence: 99%
“…Ligand/receptor targeting has proven to be an effective method for drug delivery [ 108 , 109 ]. To improve effectiveness, chemotherapeutic agents need to be administered into the cytoplasm of cellular tumor cells, or into subcellular organelles such as the nucleus and mitochondria [ 110 ]. If a linker is involved, a stable covalent bond formation is essential between the linker/receptor and the drug.…”
Section: Cancer Nanopharmaceuticalsmentioning
confidence: 99%